Chapter: Medicine and surgery: Musculoskeletal system

Osteoporosis - Metabolic bone disorders

A disease characterised by low bone mass and microarchitectural disruption. It is diagnosed if the race/sex matched bone density falls below 2.5 standard deviations from the average young bone density (WHO). - Definition, Incidence, Age, Sex, Aetiology, Pathophysiology, Clinical features, Complications, Investigations, Management, Prognosis.

Metabolic bone disorders

 

Osteoporosis

 

Definition

 

A disease characterised by low bone mass and microarchitectural disruption. It is diagnosed if the race/sex matched bone density falls below 2.5 standard deviations from the average young bone density (WHO).

 

Incidence

 

Overall 30% of individuals will have a pathological fracture due to osteoporosis.

 

Age

 

Females over 50 and males over 55 years.

 

Sex

 

2F : 1M

 

Aetiology

 

Bone is continually being remodelled involving reabsorption and synthesis. It is thought that osteoporosis results from a long-term slight imbalance between the two processes. The risk of fractures increases with bone loss and hence with age. Factors that can affect the remodelling balance are as follows:

 

Sex: Females have a lower bone mass and a high rate of bone loss in the decade following the menopause. This is largely oestrogen-dependent, early menopause and ovariectomy without hormone replacement therapy predisposes. Gonadal failure and androgen insensitivity are risk factors for osteoporosis in men.

 

Age: Agerelated bone loss is seen in both sexes; although worse in females, this may be due to decreased calcium absorption.

 

Genetic factors implicated include the vitamin D receptors and collagen genes.

Diseases such as Cushing’s syndrome, type I diabetes mellitus, thyrotoxicosis, acromegaly, hyperparathyroidism, rheumatoid arthritis and chronic renal failure.

 

Drugs can worsen/cause osteoporosis including systemic corticosteroids, ciclosporin and cytotoxic drugs.

Smoking increases the risk of osteoporosis.

 

Pathophysiology

 

Although there is low bone mass it is normally mineralised. There is disruption of the normal architecture, with fewer and thinner bony spicules and non-supporting horizontal ‘struts’ that do not join up to any other structure. The structural integrity of the bone is reduced, causing skeletal fragility.

 

Clinical features

 

Osteoporosis is not itself painful; however, the fractures that result are. Typical sites include the vertebrae, distal radius (Colles’ fracture) and the neck of the femur. Other symptoms of vertebral involvement are loss of height and increasing kyphosis.

 

Investigations

 

Bone density scanning (dual X-ray absorptiometry, i.e. DEXA scan) is the gold standard for diagnosis.

 

X-ray investigation shows fractures, a bone scan can be used to demonstrate recent fractures. The generalised bone density is difficult to assess as the appearance is dependent on the X-ray penetration.

 

Serum calcium, phosphate and alkaline phosphatase are normal.

 

Bone biopsy can be performed to confirm the diagnosis.

 

Management

 

Non-pharmacological interventions include adequate nutrition (calories, calcium and vitamin D), exercise and quitting smoking.

 

Bisphosphonates inhibit bone reabsorption and are increasingly being used for the prevention and treatment of osteoporosis.

 

Oestrogen therapy in postmenopausal women is protective; however, because of the increased risk of breast cancer and thromboembolic disease it is not recommended for the prevention of osteoporosis. Males with gonadal failure benefit from androgens.

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Medicine and surgery: Musculoskeletal system : Osteoporosis - Metabolic bone disorders |

Related Topics

Medicine and surgery: Musculoskeletal system


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.